<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38724221</PMID><DateCompleted><Year>2024</Year><Month>05</Month><Day>09</Day></DateCompleted><DateRevised><Year>2024</Year><Month>06</Month><Day>10</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2052-4439</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>May</Month><Day>09</Day></PubDate></JournalIssue><Title>BMJ open respiratory research</Title><ISOAbbreviation>BMJ Open Respir Res</ISOAbbreviation></Journal><ArticleTitle>Psychometric analysis of the modified COVID-19 Yorkshire Rehabilitation Scale (C19-YRSm) in a prospective multicentre study.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e002271</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1136/bmjresp-2023-002271</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Long COVID (LC) is a novel multisystem clinical syndrome affecting millions of individuals worldwide. The modified COVID-19 Yorkshire Rehabilitation Scale (C19-YRSm) is a condition-specific patient-reported outcome measure designed for assessment and monitoring of people with LC.</AbstractText><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To evaluate the psychometric properties of the C19-YRSm in a prospective sample of people with LC.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">1314 patients attending 10 UK specialist LC clinics completed C19-YRSm and EuroQol 5D-5L (EQ-5D-5L) longitudinally. Scale characteristics were derived for C19-YRSm subscales (Symptom Severity (SS), Functional Disability (FD) and Overall Health (OH)) and internal consistency (Cronbach's alpha). Convergent validity was assessed using the Functional Assessment of Chronic Illness Therapy (FACIT)-Fatigue Scale. Known groups validity was assessed for the Other Symptoms subscale as tertiles, as well as by hospitalisation and intensive care admission. Responsiveness and test-retest reliability was evaluated for C19-YRSm subscales and EQ-5D-5L. The minimal important difference (MID) and minimal clinically important difference (MCID) were estimated. Confirmatory factor analysis was applied to determine the instrument's two-factor structure.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">C19-YRSm demonstrated good scale characteristic properties. Item-total correlations were between 0.37 and 0.65 (for SS and FD), with good internal reliability (Cronbach's alphas&gt;0.8). Item correlations between subscales ranged between 0.46 and 0.72. Convergent validity with FACIT was good (-0.46 to -0.62). The three subscales discriminated between different levels of symptom burden (p&lt;0.001) and between patients admitted to hospital and intensive care. There was moderate responsiveness for the three subscales ranging from 0.22 (OH) to 0.50 (SS) which was greater than for the EQ-5D-5L. Test-retest reliability was good for both SS 0.86 and FD 0.78. MID was 2 for SS, 2 for FD and 1 for OH; MCID was 4 for both the SS and FD. The factor analysis supported the two-factor SS and FD structure.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The C19-YRSm is a condition-specific, reliable, valid and responsive patient-reported outcome measure for LC.</AbstractText><CopyrightInformation>&#xa9; Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Adam</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-5750-7772</Identifier><AffiliationInfo><Affiliation>Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK a.b.smith@leeds.ac.uk.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Leeds Institute for Data Analytics, University of Leeds, Leeds, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Greenwood</LastName><ForeName>Darren</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Leeds Institute for Data Analytics, University of Leeds, Leeds, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Horton</LastName><ForeName>Mike</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Academic Department of Rehabilitation Medicine, University of Leeds, Leeds, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Osborne</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goodwin</LastName><ForeName>Madeline</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lawrence</LastName><ForeName>Rom&#xe1;n Rocha</ForeName><Initials>RR</Initials><AffiliationInfo><Affiliation>ELAROS 24/7 Digital Company, Sheffield, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Winch</LastName><ForeName>Darren</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Kent &amp; Medway ICB Patient Reference Group, Kent, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Hertfordshire Community NHS Trust, Welwyn Garden City, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Milne</LastName><ForeName>Ruairidh</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>University of Southampton, Southampton, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>LOCOMOTION consortium</CollectiveName></Author><Author ValidYN="Y"><LastName>Sivan</LastName><ForeName>Manoj</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>COVID Rehabilitation Service, Leeds Community Healthcare NHS Trust, Leeds, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Demonstration Centre of Rehabilitation Medicine, Leeds Teaching Hospitals NHS Trust, Leeds, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>05</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMJ Open Respir Res</MedlineTA><NlmUniqueID>101638061</NlmUniqueID><ISSNLinking>2052-4439</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011594" MajorTopicYN="Y">Psychometrics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000071066" MajorTopicYN="Y">Patient Reported Outcome Measures</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006113" MajorTopicYN="N" Type="Geographic">United Kingdom</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Patient Outcome Assessment</Keyword></KeywordList><CoiStatement>Competing interests: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>12</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>4</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>5</Month><Day>10</Day><Hour>0</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>5</Month><Day>10</Day><Hour>0</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>5</Month><Day>9</Day><Hour>21</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>5</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38724221</ArticleId><ArticleId IdType="pmc">PMC11086182</ArticleId><ArticleId IdType="doi">10.1136/bmjresp-2023-002271</ArticleId><ArticleId IdType="pii">11/1/e002271</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Davis HE, McCorkell L, Vogel JM, et al. . Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol 2023;21:133&#x2013;46. 10.1038/s41579-022-00846-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>
Office for National Statistics . Prevalence of ongoing symptoms following Coronavirus (COVID-19) infection in the UK. 2023. Available: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/prevalenceofongoingsymptomsfollowingcoronaviruscovid19infectionintheuk/2february2023
</Citation></Reference><Reference><Citation>Chen C, Haupert SR, Zimmermann L, et al. . Global prevalence of post-coronavirus disease 2019 (COVID-19) condition or long COVID: a meta-analysis and systematic review. J Infect Dis 2022;226:1593&#x2013;607. 10.1093/infdis/jiac136</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac136</ArticleId><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, et al. . Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine 2021;38:101019. 10.1016/j.eclinm.2021.101019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Callard F, Perego E. How and why patients made long covid. Soc Sci Med 2021;268:113426. 10.1016/j.socscimed.2020.113426</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.socscimed.2020.113426</ArticleId><ArticleId IdType="pmc">PMC7539940</ArticleId><ArticleId IdType="pubmed">33199035</ArticleId></ArticleIdList></Reference><Reference><Citation>Sivan M, Rayner C, Delaney B. Fresh evidence of the scale and scope of long Covid. BMJ 2021;373:853. 10.1136/bmj.n853</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n853</ArticleId><ArticleId IdType="pubmed">33795224</ArticleId></ArticleIdList></Reference><Reference><Citation>Sivan M, Halpin S, Gee J, et al. . Assessing long-term rehabilitation needs in COVID-19 survivors using a telephone screening tool (C19-YRS tool). ACNR 2020;19:14&#x2013;7. 10.47795/NELE5960</Citation><ArticleIdList><ArticleId IdType="doi">10.47795/NELE5960</ArticleId></ArticleIdList></Reference><Reference><Citation>Parkin A, Davison J, Tarrant R, et al. . A multidisciplinary NHS COVID-19 service to manage post-COVID-19 syndrome in the community. J Prim Care Community Health 2021;12:21501327211010994. 10.1177/21501327211010994</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/21501327211010994</ArticleId><ArticleId IdType="pmc">PMC8064663</ArticleId><ArticleId IdType="pubmed">33880955</ArticleId></ArticleIdList></Reference><Reference><Citation>Yilmaz Gokmen G, Durmaz D, Demir C, et al. . Determining post-COVID-19 symptoms and rehabilitation needs in hospitalized and nonhospitalized COVID-19 survivors with tele-assessment methods. Telemed J E Health 2023;29:1312&#x2013;23. 10.1089/tmj.2022.0349</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/tmj.2022.0349</ArticleId><ArticleId IdType="pubmed">36757300</ArticleId></ArticleIdList></Reference><Reference><Citation>Straudi S, Manfredini F, Baroni A, et al. . Construct validity and responsiveness of the COVID-19 Yorkshire rehabilitation scale (C19-YRS) in a cohort of Italian hospitalized COVID-19 patients. Int J Environ Res Public Health 2022;19:6696. 10.3390/ijerph19116696</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph19116696</ArticleId><ArticleId IdType="pmc">PMC9180312</ArticleId><ArticleId IdType="pubmed">35682280</ArticleId></ArticleIdList></Reference><Reference><Citation>Sivan M, Halpin S, Gees J, et al. . The self-report version and digital format of the COVID-19 Yorkshire rehabilitation scale (C19-YRS) for long Covid or post-COVID syndrome assessment and monitoring. ACNR 2021;20:1&#x2013;5. 10.47795/QROO4168</Citation><ArticleIdList><ArticleId IdType="doi">10.47795/QROO4168</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf3;pez-L&#xf3;pez L, Calvache-Mateo A, Ortiz-Rubio A, et al. . Differences of disabling symptoms between previously hospitalized or non-hospitalized currently working long-COVID survivors one year after infection: a descriptive study. Healthcare 2023;11:2306. 10.3390/healthcare11162306</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/healthcare11162306</ArticleId><ArticleId IdType="pmc">PMC10454028</ArticleId><ArticleId IdType="pubmed">37628505</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang D, Chung VC-H, Chan DC-C, et al. . Determinants of post-COVID-19 symptoms among adults aged 55 or above with chronic conditions in primary care: data from a prospective cohort in Hong Kong. Front Public Health 2023;11:1138147. 10.3389/fpubh.2023.1138147</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2023.1138147</ArticleId><ArticleId IdType="pmc">PMC10196359</ArticleId><ArticleId IdType="pubmed">37213637</ArticleId></ArticleIdList></Reference><Reference><Citation>Partiprajak S, Krongthaeo S, Piaseu N, et al. . The Thai version of the COVID-19 Yorkshire rehabilitation scale: a valid instrument for the psychometric assessment of the community members in Bangkok, Thailand. BMC Public Health 2023;23:663. 10.1186/s12889-023-15566-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12889-023-15566-2</ArticleId><ArticleId IdType="pmc">PMC10088103</ArticleId><ArticleId IdType="pubmed">37041552</ArticleId></ArticleIdList></Reference><Reference><Citation>Kabir MF, Yin KN, Jeffree MS, et al. . Profile of long COVID symptoms needing rehabilitation: a cross-sectional household survey of 12,925 SARS-CoV-2 cases between July and December 2021 in Bangladesh. Arch Public Health 2023;81:132. 10.1186/s13690-023-01140-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13690-023-01140-0</ArticleId><ArticleId IdType="pmc">PMC10351147</ArticleId><ArticleId IdType="pubmed">37461092</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayuso Garc&#xed;a B, Besteiro Balado Y, P&#xe9;rez L&#xf3;pez A, et al. . Assessment of post-COVID symptoms using the C19-YRS tool in a cohort of patients from the first pandemic wave in northwestern Spain. Telemed J E Health 2023;29:278&#x2013;83. 10.1089/tmj.2022.0085</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/tmj.2022.0085</ArticleId><ArticleId IdType="pubmed">35727139</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho FF, Xu S, Kwong TMH, et al. . Prevalence, patterns, and clinical severity of long COVID among Chinese medicine telemedicine service users: preliminary results from a cross-sectional study. Int J Environ Res Public Health 2023;20:1827. 10.3390/ijerph20031827</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph20031827</ArticleId><ArticleId IdType="pmc">PMC9914360</ArticleId><ArticleId IdType="pubmed">36767195</ArticleId></ArticleIdList></Reference><Reference><Citation>Sivan M, Preston N, Parkin A, et al. . The modified COVID-19 Yorkshire rehabilitation scale (C19-YRSm) patient-reported outcome measure for long Covid or post-COVID-19 syndrome. J Med Virol 2022;94:4253&#x2013;64. 10.1002/jmv.27878</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27878</ArticleId><ArticleId IdType="pmc">PMC9348420</ArticleId><ArticleId IdType="pubmed">35603810</ArticleId></ArticleIdList></Reference><Reference><Citation>Kustura L, Bobek D, Polji&#x10d;anin A, et al. . Psychometric properties and observational data for COVID-19 Yorkshire rehabilitation scale (C19-YRSm) for post-COVID-19 syndrome. QJM 2024;117:38&#x2013;47. 10.1093/qjmed/hcad224</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/qjmed/hcad224</ArticleId><ArticleId IdType="pubmed">37788123</ArticleId></ArticleIdList></Reference><Reference><Citation>Sivan M, Greenhalgh T, Darbyshire JL, et al. . Long covid multidisciplinary consortium optimising treatments and servIces across the NHS (LOCOMOTION): protocol for a mixed-methods study in the UK. BMJ Open 2022;12:e063505. 10.1136/bmjopen-2022-063505</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2022-063505</ArticleId><ArticleId IdType="pmc">PMC9114312</ArticleId><ArticleId IdType="pubmed">35580970</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute for Health and Care Excellence (NICE) . COVID-19 rapid guideline: managing the long-term effects of COVID-19. NICE guideline [NG188]. 2024.</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>Sivan M, Rocha Lawrence R, O&#x2019;Brien P. Digital patient reported outcome measures platform for post-COVID-19 condition and other long-term conditions: user-centered development and technical description. JMIR Hum Factors 2023;10:e48632. 10.2196/48632</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/48632</ArticleId><ArticleId IdType="pmc">PMC10592725</ArticleId><ArticleId IdType="pubmed">37665334</ArticleId></ArticleIdList></Reference><Reference><Citation>Yellen SB, Cella DF, Webster K, et al. . Measuring fatigue and other anemia-related symptoms with the functional assessment of cancer therapy (FACT) measurement system. J Pain Symptom Manage 1997;13:63&#x2013;74. 10.1016/s0885-3924(96)00274-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0885-3924(96)00274-6</ArticleId><ArticleId IdType="pubmed">9095563</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartung TJ, Neumann C, Bahmer T, et al. . Fatigue and cognitive impairment after COVID-19: a prospective multicentre study. EClinicalMedicine 2022;53:101651. 10.1016/j.eclinm.2022.101651</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101651</ArticleId><ArticleId IdType="pmc">PMC9482331</ArticleId><ArticleId IdType="pubmed">36133318</ArticleId></ArticleIdList></Reference><Reference><Citation>Herdman M, Gudex C, Lloyd A, et al. . Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res 2011;20:1727&#x2013;36. 10.1007/s11136-011-9903-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11136-011-9903-x</ArticleId><ArticleId IdType="pmc">PMC3220807</ArticleId><ArticleId IdType="pubmed">21479777</ArticleId></ArticleIdList></Reference><Reference><Citation>van Hout B, Janssen MF, Feng Y-S, et al. . Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets. Value Health 2012;15:708&#x2013;15. 10.1016/j.jval.2012.02.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jval.2012.02.008</ArticleId><ArticleId IdType="pubmed">22867780</ArticleId></ArticleIdList></Reference><Reference><Citation>Norman GR, Sloan JA, Wyrwich KW. Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care 2003;41:582&#x2013;92. 10.1097/01.MLR.0000062554.74615.4C</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.MLR.0000062554.74615.4C</ArticleId><ArticleId IdType="pubmed">12719681</ArticleId></ArticleIdList></Reference><Reference><Citation>Steiger JH. Structural model evaluation and modification: an interval estimation approach. Multivariate Behav Res 1990;25:173&#x2013;80. 10.1207/s15327906mbr2502_4</Citation><ArticleIdList><ArticleId IdType="doi">10.1207/s15327906mbr2502_4</ArticleId><ArticleId IdType="pubmed">26794479</ArticleId></ArticleIdList></Reference><Reference><Citation>Bentler PM. Comparative fit indexes in structural models. Psychol Bull 1990;107:238&#x2013;46. 10.1037/0033-2909.107.2.238</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/0033-2909.107.2.238</ArticleId><ArticleId IdType="pubmed">2320703</ArticleId></ArticleIdList></Reference><Reference><Citation>Bentler PM, Bonett DG. Significance tests and goodness of fit in the analysis of covariance structures. Psychological Bulletin 1980;88:588&#x2013;606. 10.1037/0033-2909.88.3.588</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/0033-2909.88.3.588</ArticleId></ArticleIdList></Reference><Reference><Citation>Tucker LR, Lewis C. A reliability coefficient for maximum likelihood factor analysis. Psychometrika 1973;38:1&#x2013;10. 10.1007/BF02291170</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF02291170</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu L, Bentler PM. Cutoff criteria for fit indexes in covariance structure analysis: conventional criteria versus new alternatives. Structural Equation Modeling: A Multidisciplinary Journal 1999;6:1&#x2013;55. 10.1080/10705519909540118</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10705519909540118</ArticleId></ArticleIdList></Reference><Reference><Citation>Browne MW, Cudeck R. Alternative ways of assessing model fit. In: Bollen KA, Long JS, eds. Testing structural equation models. Newbury Park, CA: Sage, 1993: 136&#x2013;62.</Citation></Reference><Reference><Citation>National Institute for Health and Care Research (NIHR) . Living with Covid19 &#x2013; second review. 2021.</Citation></Reference><Reference><Citation>Ziauddeen N, Gurdasani D, O&#x2019;Hara ME, et al. . Characteristics and impact of long Covid: findings from an online survey. PLOS ONE 2022;17:e0264331. 10.1371/journal.pone.0264331</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0264331</ArticleId><ArticleId IdType="pmc">PMC8903286</ArticleId><ArticleId IdType="pubmed">35259179</ArticleId></ArticleIdList></Reference><Reference><Citation>Hughes SE, Haroon S, Subramanian A, et al. . Development and validation of the symptom burden questionnaire for long Covid (SBQ-LC): Rasch analysis. BMJ 2022;377:e070230. 10.1136/bmj-2022-070230</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2022-070230</ArticleId><ArticleId IdType="pmc">PMC9043395</ArticleId><ArticleId IdType="pubmed">35477524</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>